🔬 Join Corina Dutcus, MD, SVP at Eisai, in a video interview discussing the phase 3 CLEAR study. Explore how lenvatinib + pembrolizumab transform advanced ccRCC treatment. Watch here: [video]https://buff.ly/3u0FV4o Eisai US ESMO - European Society for Medical Oncology